Use of modulators of nicotinic receptors for treatment of cognitive dysfunction

Details for Australian Patent Application No. 2003215227 (hide)

Owner Davis, B.

Inventors Davis, Bonnie

Agent Spruson & Ferguson

Pub. Number AU-B-2003215227

PCT Number PCT/US03/04495

PCT Pub. Number WO2003/071922

Priority 60/358,917 22.02.02 US; 10/099,858 14.03.02 US

Filing date 18 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 26 June 2008

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/465 (2006.01) - Nicotine

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/26 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/358,917 22.02.02 US; 10/099,858 14.03.02 US

16 October 2003 Application Open to Public Inspection

  Published as AU-B-2003215227

26 June 2008 Application Accepted

  Published as AU-B-2003215227

23 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215228-PARTITION PANEL WITH MODULAR APPLIANCE MOUNTING ARRANGEMENT

2003215226-VOICE-CONTROLLED DATA ENTRY